Cat: IPD-X35606

Recombinant Mouse CLEC-2 Protein (HEK293),hFc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    CLEC-2

  • 简介

    The CLEC1B/CLEC-2 protein serves as a platelet receptor for PDPN. When activated, it signals through SRC and SYK kinases, activating PLCG2. CLEC1B forms homodimers and interacts with RACK1, promoting its ubiquitination and degradation. It also interacts with SYK and PDPN, independently of glycosylation, activating CLEC1B/CLEC-2. CLEC1B/CLEC-2 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CLEC1B/CLEC-2 protein, expressed by HEK293 , with N-hFc labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its binding ability in a functional ELISA. When Recombinant Mouse Podoplanin is coated at 1.0 µg/mL (100 μL/well), Recombinant Mouse CLEC-2 binds with ED50 of 0.2387 μg/mL. Measured by its binding ability in a functional ELISA. When Recombinant Mouse Podoplanin is coated at 1.0 µg/mL (100 μL/well), Recombinant Mouse CLEC-2 binds with ED50 of 0.2387 μg/mL.

  • Alternative Names

    C-type lectin domain family 1 member B; CLEC1B; CLEC2

  • Species

    Mouse

  • Source

    HEK293

  • Tag

    N-hFc

  • Purity

    Greater than 95% as determined by SDS-PAGE.

  • Uniprot

    Q9JL99-1

  • Expression Region

    M53-L229

  • Protein Length

    Extracellular Domain

  • Molecular Weight

    50-65 kDa.

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

CLEC-2 (C-type lectin-like receptor 2) is a pivotal receptor primarily expressed on dendritic cells and platelets, playing a crucial role in the immune system and hemostasis. It is known for its ability to recognize specific glycans found on pathogens and activated platelets, thereby mediating immune responses and thrombosis. The significance of CLEC-2 in various physiological and pathological processes has garnered considerable attention, particularly in tumor immunity and infectious diseases. Research indicates that CLEC-2 is involved in dendritic cell maturation and T-cell activation, influencing how the immune system responds to foreign antigens. Additionally, its role in platelet activation suggests that CLEC-2 could be a potential therapeutic target for anticoagulant strategies. Given the increasing incidence of thromboembolic diseases globally, understanding CLEC-2's structure and function is critical for developing novel treatments. Consequently, recombinant CLEC-2 protein research has become a focal point, aiming to elucidate its molecular mechanisms, interactions, and potential applications in immunotherapy and thrombosis management. Moreover, producing recombinant CLEC-2 enables the exploration of its structural biology and can facilitate the design of specific inhibitors or agonists to modulate its activity in clinical settings. The investigation of CLEC-2 continues to be a promising area of research in immunology and hematology, with implications for enhancing therapeutic strategies against various diseases.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US